I'm registered for BIO Partnering @JPM Week - join me to use the BIO One-on-One Partnering system! https://lnkd.in/gqvfqDF8
关于我们
Saros Therapeutics is working to enhance patients' response to immunotherapy by harnessing the STING pathway with a strategy to overcome the limitations of prior STING agonists. In combination with existing immunotherapies, this approach has the potential to enable a safe and more effective immune response against the tumor than with immunotherapy alone.
- 网站
-
https://www.sarostx.com/
Saros Therapeutics的外部链接
- 所属行业
- 生物技术
- 规模
- 2-10 人
- 总部
- Chicago
- 类型
- 私人持股
地点
-
主要
获取路线
US，Chicago
Saros Therapeutics员工
-
Tom Denison
CEO @ SmartHealth Catalyzer, Inc. | Biomedical Venture Creation
-
Matt Martin
Biotech investor and entrepreneur bringing research to the clinic
-
Yu Leo Lei
Associate Professor of Head and Neck Surgery (tenured), of Cancer Biology, and of Translational Molecular Pathology, the University of Texas M.D…
-
Eileah Loda
Postdoctoral Research Scientist
动态
-
Richard Johnson and Matt Martin welcoming Saros' newest team member: Senior Scientist Oana Teodora Truica (Marisca). Oana is bringing a wealth of relevant nanoparticle experience and great enthusiasm to develop new therapeutics. Welcome!
-
-
I am delighted that Saros Therapeutics is participating in the Creative Destruction Lab #cancer stream. Thank you to all of the mentors for your feedback and ideas!
-